Alternatives to Everads Therapy

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Developing novel therapeutic approaches for ocular diseases.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

AI-driven digital twin of embryo development for cell-based therapies.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Biotechnology company developing novel therapies for multiple myeloma.

Omnix Medical is developing a novel platform for advanced wound care management.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging.

Compressing biology to develop the next generation of therapies.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Biotechnology company developing potentially curative cell therapies for cancer patients.